SCHEMBL23345014

SCHEMBL23345014

CC(=O)N1CCC(N)(C(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
USP2 O75604 3/20 0.39
ALDH1A1 P00352 3/20 0.38
CYP2C19 P33261 3/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP2C9 P11712 4/20 0.37
TSHR P16473 1/20 0.37
CYP2D6 P10635 2/20 0.36
CYP3A4 P08684 2/20 0.36
EPHX2 P34913 3/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309174 0.78 CYP1A2 (0.44) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL23077821 0.77 CYP1A2 (0.43) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL23309207 0.77 CYP1A2 (0.43) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL16886311 0.76 MEN1 (0.39) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL584005 0.76 CYP1A2 (0.46) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL26812142 0.76 CYP1A2 (0.46) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL23344996 0.75 CYP1A2 (0.41) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL16887675 0.74 CYP1A2 (0.44) CYP1A2TDP1KDM4ESMN1; SMN2USP2
Hydrochloric Acid SCHEMBL30747450 0.74 CYP1A2 (0.44) CYP1A2TDP1KDM4ESMN1; SMN2USP2
SCHEMBL23049641 0.72 USP2 (0.43) CYP1A2TDP1KDM4ESMN1; SMN2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168102-B1 Bicyclic heteroaryl compounds and uses thereof Revolution Medicines, Inc. (US) 2021-11-09 US disclosed
US-20210139517-A1 BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF Revolution Medicines, Inc. 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11168102-B1 Bicyclic heteroaryl compounds and uses thereof SOS1, SOST, SOS2 CYP1A2 1997/4885TDP1 2014/4885KDM4E 4779/4885
US-20210139517-A1 BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF SOST, SOS1, SOS2 CYP1A2 2086/4885TDP1 1675/4885KDM4E 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.